Holen Sie sich die Stockscreener-App
23.64
2.74%
0.63
Finanzdaten der Janux Therapeutics Inc-Aktie (JANX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | 0.439 | 8.897 |
| Research and Development |
38.35%
34.66
|
25.05 | - | - | - |
| Operating Income/Loss |
29.29%
-45.12
|
-34.90 | -29.02 | -35.84 | -13.82 |
| Nonoperating Income/Loss |
1.13%
11.26
|
11.39 | 8.806 | 7.783 | 7.863 |
| Income/Loss From Continuing Operations Before Tax |
44.03%
-33.86
|
-23.51 | -20.22 | -28.06 | -5.959 |
| Income/Loss From Continuing Operations After Tax |
44.03%
-33.86
|
-23.51 | -20.22 | -28.06 | -5.959 |
Net Income/Loss
|
44.03%
-33.86
|
-23.51 | -20.22 | -28.06 | -5.959 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.18%
61.90
|
61.79 | 1.0345 | 54.63 | 54.45 |
| Diluted Average Shares |
0.18%
61.90
|
61.79 | 1.0345 | 54.63 | 54.45 |
| Basic Earnings Per Share |
44.74%
-0.55
|
-0.38 | -0.35 | -0.51 | -0.11 |
| Diluted Earnings Per Share |
44.74%
-0.55
|
-0.38 | -0.35 | -0.51 | -0.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):